Increased risk of gastrointestinal adverse effects under SSRI/NSAID combination may be due to pharmacokinetic interactions

de Jong, Jeroen C. F.
Brouwers, Jacobus R. B. J.
de Jong-van den Berg, Lolkje T. W.

Department of Social Pharmacy and Pharmacoepidemiology, Groningen University Institute for Drug Exploration, (GUIDE), University Centre for Pharmacy, Groningen, The Netherlands

Correspondence Dr L. T. W. de Jong-van den Berg, Department of Social Pharmacy and Pharmacoepidemiology, Groningen University Institute for Drug Exploration, (GUIDE), A. Deusinglaan 1, 9713 AV Groningen, The Netherlands. E-mail: [email protected]

British Journal of Clinical Pharmacology 59(1):p 119, January 2005.